Research Lab Pipeline - Helen-Marie Dunmore

At MCPF we talk a lot about our global approach to spinal cord injury research and how it takes a lot of time. During this episode of Spinal Cast Helen-Marie Dunmore, Principal Scientific Advisor with Charles River Laboratories, United Kingdom shares some insight on why it takes so long and how their work is critical for safe and reliable therapies for those affected by spinal cord injury. We discuss the role of regulation, new drug trials, blood brain barrier, data sets, pre-clinical testing, animal models, functional methods, collaboration, and standardization – just to name a few of the challenges. We also hear about the promising therapeutic targets that Helen-Marie is especially excited about; protection and regeneration of neurons, tissue repair, cell and gene-based therapies. Yep, it all takes time, a lot of time, and money.

The ...